Tevogen Bio Holdings Inc.TVGN

$9.46-0.24 (-2.47%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$33M

Micro-cap

-94%

2022 — today

10-Year Price

-98%

2022 — today

52-Week Range

$4.29$63.00

Current $9.46· 9%

Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology. Its flagship experimental product, TVGN 489, is a precision T cell therapeutic engineered to address critical unmet needs in patients with acute-risk COVID-19, alongside a specific population experiencing long COVID. The company's operations are headquartered in Warren, New Jersey.

Valuation in context

P/E ratio

-1.6

N/A

Not meaningful — company is unprofitable

P/B ratio

-3.4

N/A

Not meaningful — company is unprofitable

FCF Yield

-35.8%

Near historic low

Near historic low — last 10 years

Free · No credit card needed

Get alerted when TVGN is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.